Real-world evidence of first-line cetuximab (CX) plus paclitaxel (PX) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
B. Cirauqui Cirauqui, J. Martinez Trufero,M. Plana Serrahima, A. Garcia Castano, J. Rubio-Casadevall, A. Carral Maseda,L. Iglesias Docampo, P. Perez Segura,I. Ceballos Lenza,V. Gutierrez Calderon, J. Fuster Salva, C. Pena Alvarez, V. Arrazubi Arrula,E. del Barco Morillo, M. Chaves Conde, J. Martinez Galan, M. Duran Sanchez,V. Quiroga, E. Ortega,R. Mesia Nin Annals of Oncology（2022）
AI 理解论文
溯源树
样例
